Tamás Tábi

1.3k total citations
70 papers, 1.0k citations indexed

About

Tamás Tábi is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tamás Tábi has authored 70 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 22 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tamás Tábi's work include Neuroscience and Neuropharmacology Research (8 papers), Microfluidic and Capillary Electrophoresis Applications (8 papers) and Amino Acid Enzymes and Metabolism (7 papers). Tamás Tábi is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Microfluidic and Capillary Electrophoresis Applications (8 papers) and Amino Acid Enzymes and Metabolism (7 papers). Tamás Tábi collaborates with scholars based in Hungary, United States and Germany. Tamás Tábi's co-authors include Éva Szökő, K. Magyar, László Vécsei, István Vincze, Peter Riederer, András Csillag, Moussa B. H. Youdim, Peter Riederer, Gergely Zachár and Huba Kalász and has published in prestigious journals such as Analytical Biochemistry, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tamás Tábi

68 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamás Tábi Hungary 18 291 164 156 153 141 70 1.0k
Yuqiang Wang China 20 384 1.3× 91 0.6× 106 0.7× 108 0.7× 92 0.7× 62 1.0k
Éva Szökő Hungary 20 386 1.3× 155 0.9× 366 2.3× 622 4.1× 161 1.1× 82 1.6k
Tomaž Vovk Slovenia 19 229 0.8× 143 0.9× 68 0.4× 73 0.5× 183 1.3× 53 1.3k
Abdul Basit United States 23 575 2.0× 132 0.8× 99 0.6× 63 0.4× 102 0.7× 56 1.3k
Fumiyo Kasuya Japan 21 412 1.4× 231 1.4× 135 0.9× 50 0.3× 237 1.7× 67 1.1k
Charan Singh India 19 465 1.6× 158 1.0× 51 0.3× 94 0.6× 86 0.6× 90 1.4k
Joana Bicker Portugal 19 361 1.2× 108 0.7× 81 0.5× 106 0.7× 145 1.0× 53 1.3k
Luana Heimfarth Brazil 23 606 2.1× 164 1.0× 55 0.4× 57 0.4× 156 1.1× 79 1.8k
Yujuan Li China 21 579 2.0× 185 1.1× 50 0.3× 59 0.4× 70 0.5× 102 1.5k

Countries citing papers authored by Tamás Tábi

Since Specialization
Citations

This map shows the geographic impact of Tamás Tábi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Tábi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Tábi more than expected).

Fields of papers citing papers by Tamás Tábi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Tábi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Tábi. The network helps show where Tamás Tábi may publish in the future.

Co-authorship network of co-authors of Tamás Tábi

This figure shows the co-authorship network connecting the top 25 collaborators of Tamás Tábi. A scholar is included among the top collaborators of Tamás Tábi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamás Tábi. Tamás Tábi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szökő, Éva, et al.. (2025). Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 26(21). 10787–10787. 1 indexed citations
2.
Tábi, Tamás, et al.. (2025). Resveratrol restores insulin signaling and balances mitochondrial biogenesis and autophagy in streptozotocin-induced neurodegeneration in vitro. European Journal of Pharmaceutical Sciences. 212. 107202–107202. 2 indexed citations
6.
Király, Kornél, Pál Riba, Zoltán Zádori, et al.. (2023). Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats. Pharmaceuticals. 16(8). 1115–1115. 8 indexed citations
7.
Šebeková, Katarı́na, Marta Staruchová, Csilla Mišľanová, et al.. (2023). Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-To-45-Year-Old Females: A Cross-Sectional Study. Antioxidants. 12(6). 1221–1221. 6 indexed citations
8.
Tábi, Tamás, et al.. (2022). Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release. International Journal of Molecular Sciences. 23(16). 9460–9460. 5 indexed citations
9.
Scheijen, Jean L.J.M., Marjo P. H. van de Waarenburg, Radana Gurecká, et al.. (2022). Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study. Nutrients. 14(22). 4929–4929. 9 indexed citations
10.
Király, Kornél, et al.. (2022). The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action. International Journal of Molecular Sciences. 23(17). 9564–9564. 4 indexed citations
11.
Király, Kornél, Ferenc Zádor, Mihály Balogh, et al.. (2021). Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain. Molecules. 26(20). 6168–6168. 5 indexed citations
12.
Miklya, Ildikó, Júlia Tímár, Tamás Tábi, et al.. (2021). Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. International Journal of Molecular Sciences. 22(6). 2853–2853. 7 indexed citations
13.
Balogh, Mihály, Ferenc Zádor, Zoltán Zádori, et al.. (2021). Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model. International Journal of Molecular Sciences. 22(5). 2479–2479. 14 indexed citations
14.
Tábi, Tamás, et al.. (2021). Development and validation of capillary electrophoresis method for quantification of gangliosides in brain synaptosomes. Journal of Pharmaceutical and Biomedical Analysis. 205. 114329–114329. 3 indexed citations
16.
Zádori, Zoltán, Ágnes Fehér, Mahmoud Al‐Khrasani, et al.. (2016). Inhibition of α2A-Adrenoceptors Ameliorates Dextran Sulfate Sodium–Induced Acute Intestinal Inflammation in Mice. Journal of Pharmacology and Experimental Therapeutics. 358(3). 483–491. 7 indexed citations
17.
Tábi, Tamás, et al.. (2011). Comparison of quantitative performance of three fluorescence labels in CE/LIF analysis of aspartate and glutamate in brain microdialysate. Electrophoresis. 32(20). 2816–2822. 14 indexed citations
20.
Magyar, K., et al.. (2004). Pharmacological Aspects of (-)-Deprenyl. Current Medicinal Chemistry. 11(15). 2017–2031. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026